HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
USFDA concludes inspection at Zydus Lifesciences’ Vadodara manufacturing site
Apr-24-2024

United States Food and Drug Administration (USFDA) has concluded the inspection at Zydus Lifesciences’ Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from April 15 to April 23, 2024. The inspection closed with 10 observations. The Company will closely work with the USFDA to address and respond to the observations in an expeditious manner.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.

  RELATED NEWS >>